Predictive oncology stock.
The shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...
Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...Forecst.com predicts future values using technical analysis of a large number of analytical parameters. POAI stock returns are also predicted based on historical data. According to our research, POAI stock is a bad long-term investment. POAI share price has been in a bear cycle for the past year. Predictive Oncology Inc. stock trend is …The estimated Net Worth of Robert L Myers is at least $346 mil dollars as of 25 September 2023. Mr Myers owns over 1,667 units of Predictive Oncology stock worth over $18,305 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.
Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.
Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis.Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings data on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to …
Oncology Pharma Stock Forecast. Is Oncology Pharma Stock Undervalued? The current Oncology Pharma [ ONPH] share price is $0.0000. The Score for ONPH is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ONPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.Apr 20, 2023 · Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ... Predictions about the future lives of humanity are everywhere, from movies to news to novels. Some of them prove remarkably insightful, while others, less so. Luckily, historical records allow the people of the present to peer into the past...Predictive Oncology. Price today: US$0.4308. Market cap: US$33.671 million. Predictive Oncology is a company that is focused on the use of data and artificial intelligence to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.
Based on 79,403,893 shares of common stock issued and outstanding as of March 17, 2023, immediately following the Reverse Stock Split, the Company would have approximately 39,701,947 shares of common stock issued and outstanding (without giving effect to rounding for fractional shares) if the ratio for the Reverse Stock Split is one-for- …
Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ...
Nov 16, 2023 · PREDICTIVE ONCOLOGY INC. 2915 Commers Drive, Suite 900. Eagan, Minnesota 55121. Telephone: (651) 389-4800 . NOTICE OF SPECIAL MEETING OF STOCKHOLDERS The estimated Net Worth of Carl I. Schwartz is at least $1.17 Milion dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $741,217 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology.In the digital age, music has become more accessible than ever before. With just a few clicks, you can stream your favorite songs or even download them for offline listening. In the early days of digital music, users had to pay a fee to dow...COMMON STOCK PURCHASE WARRANT . PREDICTIVE ONCOLOGY INC. Warrant Shares: _____ Initial Exercise Date: February 22, 2021 . ... 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Predictive Oncology Inc., a Delaware corporation ...Predictive Oncology Inc (POAI) stock is trading at $0.29 as of 3:29 PM on Tuesday, Apr 4, a loss of -$0.02, or -5.88% from the previous closing price of $0.31. The stock has traded between $0.28 and $0.31 so far today. Volume today is 336,440 compared to average volume of 417,533.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ...
The NFL’s preseason’s about to start, and that means regular season games will be kicking off before we know it. And since we all love to predict the future way before it really makes sense to do so, it feels like a great time to take stock...Jul 18, 2023 · Predictive Oncology Inc. PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and ... What's Thomas Goldrick's mailing address? Thomas's mailing address filed with the SEC is 2915 COMMERS DRIVE, SUITE 900, , EAGAN, MN, 55121.Mar 9, 2023 · EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities ... Predictive Oncology Inc. March 14, 2023 at 8:30 AM · 3 min read. Predictive Oncology Inc. Comprehensive, multi-faceted IR program to focus on raising awareness of Predictive Oncology and its ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.
Your vote is important and easy to cast. Vote Now! Please enter your control number to view/cast your vote. Control Number. Log In ...
Predictive Oncology Inc. (POAI) Stock Price | Stock Quote Nasdaq - MarketScreener PREDICTIVE ONCOLOGY INC. Predictive Oncology Inc. Stock price …Nov 17, 2023 · As of November 16, 2023, Predictive Oncology Inc had a $12.8 million market capitalization, putting it in the 16th percentile of companies in the Medical Equipment, Supplies & Distribution industry. Predictive Oncology Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Predictive Oncology Inc. PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and ...The estimated Net Worth of J Melville Engle is at least $117 millier dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $113,900 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.95 and traded ...The estimated Net Worth of Richard L Gabriel is at least $58.5 Thousand dollars as of 1 September 2020. Mr Gabriel owns over 4,000 units of Predictive Oncology stock worth over $56,126 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $2,333 as Sr. VP of R&D at Predictive Oncology.Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precis...Mar 9, 2023 · Predictive Oncology Inc. EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and ...
EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities ...
Apr 24, 2023 · Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...
Mar 16, 2023 · The shares of Series F Preferred Stock will be distributed to such recipients a. EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology ... About Predictive Oncology (NASDAQ: POAI) The leading edge of a new frontier in drug discovery As a science-driven company on the leading edge of oncology drug discovery, Predictive Oncology offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to … About us Read More »The estimated Net Worth of Carl I. Schwartz is at least 4.75 百万$ dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over 4,318,394$ and over the last 7 years he sold POAI stock worth over 544$. In addition, he makes 433,000$ as CEO & Director at Predictive Oncology.In the world of prophecy and spirituality, Perry Stone is a well-known figure who has gained a significant following for his insights into future events. One of Perry Stone’s notable predictions revolves around economic shifts and a possibl...The first of these is Predictive Oncology (NASDAQ: POAI). The company uses a proprietary AI platform to identify drugs that are likely to work against specific tumors. To facilitate this, the ...Predictive Oncology Inc (POAI) stock is trading at $0.29 as of 3:29 PM on Tuesday, Apr 4, a loss of -$0.02, or -5.88% from the previous closing price of $0.31. The stock has traded between $0.28 and $0.31 so far today. Volume today is 336,440 compared to average volume of 417,533.Predictive Oncology “is a data and AI-driven discovery services company that provides predictive models of tumor drug response.” One of Predictive Oncology’s subsidiaries, TumorGenesis ...Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …
0.73%. $39.94B. Astellas Pharma Inc. -4.37%. ¥3.42T. PYXS | Complete Pyxis Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.May 16, 2022 · Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ... In 2023 so far, the iShares Biotechnology ETF (IBB) is down 7.5% while the S&P 500 is up more than 14%—but from 2012 to 2015, IBB beat the S&P 500 by more than 3-to-1. Picking the right biotech ...Find the latest historical data for Predictive Oncology Inc. Common Stock (POAI) at Nasdaq.com.Instagram:https://instagram. veritex bank stocknyse esis caltier a good investmenttimberland reit The estimated Net Worth of J Melville Engle is at least $86.4 Tisíc dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $83,391 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology. spts stockavuv expense ratio Nov 7, 2023 · Press Releases. Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update. Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital. Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023. The estimated Net Worth of J Melville Engle is at least $987 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $984,422 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology. best places to retire in new england Predictive Oncology has a market capitalisation of US$21m and burnt through US$13m last year, which is 64% of the company's market value. Given how large that cash burn is, relative to the market ...Apr 20, 2023 · Predictive Oncology’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol POAI and will begin trading on a split-adjusted basis when the market opens on Monday ... Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis.